pillbase.ru

COSENTYX

Active substance: secukinumab

INJECTION · SECUKINUMAB 75 mg/.5mL

United StatesActive

Marketing holder: Novartis Pharmaceuticals Corporation

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 3
  • Козэнтикс
    раствор для подкожного введения, 150 мг/мл, 2 мл (original in Russian, GRLS)
    ЛП-№(008091)-(РГ-RU)
    Новартис Фарма АГ
  • Козэнтикс
    раствор для подкожного введения, 150 мг/мл, 1 мл (original in Russian, GRLS)
    ЛП-003780
    Новартис Фарма АГ
  • Козэнтикс
    лиофилизат для приготовления раствора для подкожного введения, 150 мг, (original in Russian, GRLS)
    ЛП-003715
    Новартис Фарма АГ
EU 1
  • Cosentyx
    secukinumab
    EMEA/H/C/003729
    Novartis Europharm Limited
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-91c0-73a3-9636-6b6f9bda892b,01a120c4-b7ba-77b7-817f-cd3b0ba3b3cb,01a120c5-b8c5-7097-b65c-2b277b80b81e;count=3 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4850-71d5-8e8d-d71d47662063,01a1208f-8d57-792c-bda2-406c88c004c2,01a12091-6ceb-7e58-bb40-20fd5ae562e8,01a12093-4261-7559-b6bd-7739c8e97463;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0078-1056
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 0078-1056 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0078-1056 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0078-1056 · Verified 2026-10-09 · open in source